Development of nanoparticulate drug delivery systems based on thiolated poly(acrylic acid)

Journal of Microencapsulation

Volumn 26, Issue 3, 2009, Pages 187-194

  Thaurer, Michael H ^a   Deutel, Britta ^a   Schlocker, Wolfgang ^b   Bernkop Schnürch, Andreas ^b  

^a Thiomatrix Forschungs und Beratungs GmbH   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Cross linking; Ionic gelation; Mucoadhesion; Nanoparticles; Poly(acrylic acid); Thiomers

Indexed keywords

CALCIUM CHLORIDE; CYSTEINE; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; NANOPARTICLE; POLYACRYLIC ACID;

ARTICLE; CONJUGATION; CROSS LINKING; DISULFIDE BOND; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; FLUORESCENCE; GELATION; MOLECULAR WEIGHT;

ACRYLIC RESINS; DEXTRANS; DRUG CARRIERS; FLUORESCEIN-5-ISOTHIOCYANATE; NANOPARTICLES; PARTICLE SIZE; SULFHYDRYL COMPOUNDS;

EID: 70749108706     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040802217003     Document Type: Article

References (33)

1. Bodmeier R, Chen HG, Paeratakul O. A novel approach to the oral delivery of micro- or nanoparticles. Pharm Res. 1989;6:413-417.
2. Fahr A, Kissel T. Mikropartikel und Implantate: Arzneiformen zur parenteralen Applikation (17). In: Müller RH, Hildebrand GE, editors. Pharmazeutische Technologie-Moderne Arzneiformen. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 1998. pp 243-258.
3. Muller RH, Mader K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm. 2000;50:161-177.
4. Sameti M, Bohr G, Ravi Kumar MN, Kneuer C, Bakowsky U, et al. Stabilisation by freeze-drying of cationically modified silica nanoparticles for gene delivery. Int J Pharm. 2003;266:51-60.
5. Guzman M, Aberturas MR, Rodriguez-Puyol M, Molpeceres J. Effect of nanoparticles on digitoxin uptake and pharmacologic activity in rat glomerular mesangial cell cultures. Drug Deliv. 2000;7:215-222.
6. Lamprecht A, Ubrich N, Hombreiro PM, Lehr C, Hoffman M, Maincent P. Influences of process parameters on nanoparticle preparation performed by a double emulsion pressure homogenization technique. Int J Pharm. 2000;196:177-182.
7. Wehrle P, Magenheim B, Benita S. The influence of process parameters on the PLA nanoparticle size distribution, evaluated by means of factorial design. Eur J Pharm Biopharm. 1995;41:19-26.
8. Chacon M, Molpeceres J, Berges L, Guzman M, Aberturas MR. Stability and freeze-drying of cyclosporine loaded poly(D,L lactideglycolide) carriers. Eur J Pharm Sci. 1999;8:99-107.
9. Wang N, Wu XS, Li JK. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery. Pharm Res. 1999;16:1430-1435.
10. Ge HX, Hu Y, Yang SC, Jiang XQ, Yang CY. Preparation, characterization, and drug release behaviors of drug-loaded e-caprolactone/ L-lactide copolymer nanoparticles. J Appl Polym Sci. 2000; 75:874-882.
11. Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263:1600-1603.
12. Legrand P. Polymeric nanocapsules as drug delivery system. STP Pharm Sci. 1999;9:411-418.
13. De Jaeghere F, Allemann E, Leroux JC, Stevels W, Feijen J, Doelker E, et al. Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm Res. 1999;16:859-866.
14. Ryu J, Jeong YI, Kim IS, Lee JH, Nah JW, Kim SH. Clonazepam release from core-shell type nanoparticles of poly(epsilon-caprolactone)/- poly(ethylene glycol)/poly(epsilon-caprolactone) triblock copolymers. Int J Pharm. 2000;200:231-242.
15. Heald CR. Self-consistent field modelling of poly(lactic acid)-poly (ethylene glycol) particles. Colloids Surf A: Physico-Chem Eng Aspects. 2001;179:79-91.
16. Kriwet B, Walter E, Kissel T. Synthesis of bioadhesive poly(acrylic acid) nano- and microparticles using an inverse emulsion polymerization method for the entrapment of hydrophilic drug candidates. J Contr Rel. 1998;56:149-158.
17. De TK, Hoffmann AS. A reverse microemulsion polymerization method for preparation of bioadhesive polyacrylic acid nanoparticles for mucosal drug delivery: loading and release of timolol maleate. Artif Cells Blood Substit Immobil Biotechnol. 2001;29:31-46.
18. Lee JW, Park JH, Robinson JR. Bioadhesive-based dosage forms: the next generation. J Pharm Sci. 2000;89:850-866.
19. Kast CE, Bernkop-Schnürch A. Thiolated polymers-thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials. 2001;22:2345-2352. (Pubitemid 32666227)
20. Marschutz MK, Bernkop-Schnürch A. Thiolated polymers: selfcrosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. Eur J Pharm Sci. 2002; 15:387-394.
21. Leitner VM, Walker GF, Bernkop-Schnürch A. Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins. Eur J Pharm Biopharm. 2003;56:207-214.
22. Bernkop-Schnürch A. Mucoadhesive polymers. In: Dumitriu S, editor. Polymeric biomaterials. New York: Marcel Dekker; 2002. pp 147-165.
23. Imam ME, Hornof M, Valenta C, Bernkop-Schnurch A. Evidence for the interpenetration of mucoadhesive polymers into the mucous gel layer. STP Pharma Sci. 2003;13:171-176.
24. Greindl M, Bernkop-Schnurch A. Development of a novel method for the preparation of thiolated polyacrylic acid nanoparticles. Pharm Res. 2006;23:2183-2189.
25. Guggi D, Marschutz MK, Bernkop-Schnurch A. Matrix tablets based on thiolated poly(acrylic acid): pH-dependent variation in disintegration and mucoadhesion. Int J Pharm. 2004;274:97-105.
26. Bernkop-Schnürch A, Gilge B. Anionic mucoadhesive polymers as auxiliary agents for the peroral administration of (poly)peptide drugs: influence of the gastric juice. Drug Dev Ind Pharm. 2000; 26:107-113.
27. Habeeb AF. A sensitive method for localization of disulfide containing peptides in column effluents. Anal Biochem. 1973;56:60-65.
28. Bernkop-Schnürch A, Steininger S. Synthesis and characterisation of mucoadhesive thiolated polymers. Int J Pharm. 2000;194:239-247.
29. Vila A, Sanchez A, Janes K, Behrens I, Kissel T, Vila Jato JL, et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm. 2004; 57:123-131.
30. Bernkop-Schnürch A, Schwarz V, Steininger S. Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm Res. 1999;16:876-881. (Pubitemid 29284199)
31. Leitner VM, Guggi D, Bernkop-Schnürch A. Thiomers in noninvasive polypeptide delivery: in vitro and in vivo characterization of a polycarbophil- cysteine/glutathione gel formulation for human growth hormone. J Pharm Sci. 2004;93:1682-1691.
32. Palmberger TF, Albrecht K, Loretz B, Bernkop-Schnürch A. Thiolated polymers: evaluation of the influence of the amount of covalently attached l-cysteine to poly(acrylic acid). Eur J Pharm Biopharm. 2007;66:405-412.
33. Bernkop-Schnurch A, Krauland AH, Leitner VM, Palmberger T. Thiomers: potential excipients for non-invasive peptide delivery systems. Eur J Pharm Biopharm. 2004;58:253-263.